Head-to-head dispatch
Vaylen vs VyrarX
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
The strongest all-rounder among the newer entrants — low pricing, brand access, oral routes, and all 50 states on one account.
Desk Score
VyrarX is a LegitScript-certified telehealth platform offering compounded semaglutide (from $179/month) and compounded tirzepatide (from $329/month) via weekly injection, prescribed by licensed US physicians.
Vaylen takes this head-to-head with the higher Desk Score, 91/100 (A−) against 67/100 (C) for VyrarX. VyrarX still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Vaylen
91/100
A−
VyrarX
67/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Vaylen | VyrarX |
|---|---|---|
| Semaglutide | $179/mo | $179/mo (starting dose, compounded) |
| Tirzepatide | $239/mo | $329/mo (starting dose, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name | Yes | Compounded only |
| Oral option | Yes | Injectable only |
| Best for | People who want maximum optionality — brand or compounded, oral or injectable — without giving up nationwide reach. | Readers who want compounded semaglutide ($179/mo) and tirzepatide ($329/mo) via LegitScript-certified telehealth in 47 states. |
| Desk Score | 91/100A− | 67/100C |
The verdict
Desk pick — VaylenVaylen takes this head-to-head with the higher Desk Score, 91/100 (A−) against 67/100 (C) for VyrarX. VyrarX still holds its ground where its strengths line up with yours.
Choose Vaylen if…
People who want maximum optionality — brand or compounded, oral or injectable — without giving up nationwide reach.
$179/mo sema · $239/mo tirz · All 50 states
Choose VyrarX if…
Readers who want compounded semaglutide ($179/mo) and tirzepatide ($329/mo) via LegitScript-certified telehealth in 47 states.
$179/mo (starting dose, compounded) sema · $329/mo (starting dose, compounded) tirz · Coverage not published
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Vaylen · VyrarX.
Also on the board
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Vaylen vs CoreAge Rx
- VyrarX vs Strut Health
- Vaylen vs Ondra Health
- VyrarX vs Invigor Medical
- Vaylen vs Vytora Health
- VyrarX vs Sesame Care
Or see the full comparison hub and the complete board.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.